194 related articles for article (PubMed ID: 33144651)
1. Bidirectional, non-necrotizing glomerular crescents are the critical pathology in X-linked Alport syndrome mouse model harboring nonsense mutation of human COL4A5.
Song JY; Saga N; Kawanishi K; Hashikami K; Takeyama M; Nagata M
Sci Rep; 2020 Nov; 10(1):18891. PubMed ID: 33144651
[TBL] [Abstract][Full Text] [Related]
2. X-linked Alport Syndrome with Type IV Collagen α5 Chain Staining Revealing Normal Expression in the Glomerular Basement Membrane and Negative on Bowman's Capsule and Distal Tubular Basement Membrane: A Case Report.
Okamoto T; Shima H; Doi T; Nozu K; Inoue T; Tashiro M; Wariishi S; Bando H; Azuma H; Iwasaka N; Ohara T; Okada K; Minakuchi J
Tohoku J Exp Med; 2023 Sep; 261(1):69-73. PubMed ID: 37495524
[TBL] [Abstract][Full Text] [Related]
3. X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene.
Fu XJ; Nozu K; Eguchi A; Nozu Y; Morisada N; Shono A; Taniguchi-Ikeda M; Shima Y; Nakanishi K; Vorechovsky I; Iijima K
Clin Exp Nephrol; 2016 Oct; 20(5):699-702. PubMed ID: 26581810
[TBL] [Abstract][Full Text] [Related]
4. Plasma leakage through glomerular basement membrane ruptures triggers the proliferation of parietal epithelial cells and crescent formation in non-inflammatory glomerular injury.
Ryu M; Migliorini A; Miosge N; Gross O; Shankland S; Brinkkoetter PT; Hagmann H; Romagnani P; Liapis H; Anders HJ
J Pathol; 2012 Dec; 228(4):482-94. PubMed ID: 22553158
[TBL] [Abstract][Full Text] [Related]
5. X-Linked Alport Dogs Demonstrate Mesangial Filopodial Invasion of the Capillary Tuft as an Early Event in Glomerular Damage.
Clark SD; Nabity MB; Cianciolo RE; Dufek B; Cosgrove D
PLoS One; 2016; 11(12):e0168343. PubMed ID: 27959966
[TBL] [Abstract][Full Text] [Related]
6. Mouse model of X-linked Alport syndrome.
Rheault MN; Kren SM; Thielen BK; Mesa HA; Crosson JT; Thomas W; Sado Y; Kashtan CE; Segal Y
J Am Soc Nephrol; 2004 Jun; 15(6):1466-74. PubMed ID: 15153557
[TBL] [Abstract][Full Text] [Related]
7. Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.
Abrahamson DR; Isom K; Roach E; Stroganova L; Zelenchuk A; Miner JH; St John PL
J Am Soc Nephrol; 2007 Sep; 18(9):2465-72. PubMed ID: 17699809
[TBL] [Abstract][Full Text] [Related]
8. X-linked Alport syndrome presenting in mother and son with the same unique histopathological features.
Bergeron NAD; Garneau AP; Rousseau-Gagnon M; Riopel J; Isenring P
J Nephrol; 2024 Apr; 37(3):769-772. PubMed ID: 38668984
[TBL] [Abstract][Full Text] [Related]
9. Synaptopodin deficiency exacerbates kidney disease in a mouse model of Alport syndrome.
Ning L; Suleiman HY; Miner JH
Am J Physiol Renal Physiol; 2021 Jul; 321(1):F12-F25. PubMed ID: 34029143
[TBL] [Abstract][Full Text] [Related]
10. Somatic mosaicism for a mutation of the COL4A5 gene is a cause of mild phenotype male Alport syndrome.
Krol RP; Nozu K; Nakanishi K; Iijima K; Takeshima Y; Fu XJ; Nozu Y; Kaito H; Kanda K; Matsuo M; Yoshikawa N
Nephrol Dial Transplant; 2008 Aug; 23(8):2525-30. PubMed ID: 18332068
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of glomerular collagen IV immunofluorescence studies in male patients with X-linked Alport syndrome.
Massella L; Gangemi C; Giannakakis K; Crisafi A; Faraggiana T; Fallerini C; Renieri A; Muda AO; Emma F
Clin J Am Soc Nephrol; 2013 May; 8(5):749-55. PubMed ID: 23371956
[TBL] [Abstract][Full Text] [Related]
12. A unique evolution of the kidney phenotype in a patient with autosomal recessive Alport syndrome.
Vischini G; Kapp ME; Wheeler FC; Hopp L; Fogo AB
Hum Pathol; 2018 Nov; 81():229-234. PubMed ID: 29530752
[TBL] [Abstract][Full Text] [Related]
13. A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen α3α4α5(IV) trimers.
Korstanje R; Caputo CR; Doty RA; Cook SA; Bronson RT; Davisson MT; Miner JH
Kidney Int; 2014 Jun; 85(6):1461-8. PubMed ID: 24522496
[TBL] [Abstract][Full Text] [Related]
14. Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome.
Tanaka M; Asada M; Higashi AY; Nakamura J; Oguchi A; Tomita M; Yamada S; Asada N; Takase M; Okuda T; Kawachi H; Economides AN; Robertson E; Takahashi S; Sakurai T; Goldschmeding R; Muso E; Fukatsu A; Kita T; Yanagita M
J Clin Invest; 2010 Mar; 120(3):768-77. PubMed ID: 20197625
[TBL] [Abstract][Full Text] [Related]
15. Pathogenicity of a Human Laminin
Funk SD; Bayer RH; Malone AF; McKee KK; Yurchenco PD; Miner JH
J Am Soc Nephrol; 2018 Mar; 29(3):949-960. PubMed ID: 29263159
[TBL] [Abstract][Full Text] [Related]
16. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
17. Distribution of alpha-chains of type IV collagen in glomerular basement membranes with ultrastructural alterations suggestive of Alport syndrome.
Barsotti P; Muda AO; Mazzucco G; Massella L; Basolo B; De Marchi M; Rizzoni G; Monga G; Faraggiana T
Nephrol Dial Transplant; 2001 May; 16(5):945-52. PubMed ID: 11328899
[TBL] [Abstract][Full Text] [Related]
18. Genetic cause of X-linked Alport syndrome in a family of domestic dogs.
Cox ML; Lees GE; Kashtan CE; Murphy KE
Mamm Genome; 2003 Jun; 14(6):396-403. PubMed ID: 12879362
[TBL] [Abstract][Full Text] [Related]
19. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
Heidet L; Gubler MC
Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical and molecular genetic evidence for type IV collagen alpha5 chain abnormality in the anterior lenticonus associated with Alport syndrome.
Ohkubo S; Takeda H; Higashide T; Ito M; Sakurai M; Shirao Y; Yanagida T; Oda Y; Sado Y
Arch Ophthalmol; 2003 Jun; 121(6):846-50. PubMed ID: 12796257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
